前收市價 | 0.6130 |
開市 | 0.6174 |
買盤 | 0.6047 x 200 |
賣出價 | 0.6343 x 200 |
今日波幅 | 0.6170 - 0.6230 |
52 週波幅 | 0.5900 - 2.5300 |
成交量 | |
平均成交量 | 418,608 |
市值 | 53.977M |
Beta 值 (5 年,每月) | 0.93 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.9000 |
業績公佈日 | 無 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 13.75 |
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript March 26, 2024 BioLineRx Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2023 Financial […]
In almost every situation, investors should stay away from penny stocks. They’re extremely speculative and they tend to facilitate delusions of grandeur. To be sure, there’s nothing wrong with hope. But hope shouldn’t be a substitute for sound research and due diligence. Still, it’s also possible – in some limited sense – that you miss 100% of the shots you don’t take. Granted, I’ve got to be careful with this statement. If you take the shots, you’re more likely to miss than hit and those misses
BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript November 20, 2023 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2023 Financial Results Conference Call. All participants are presently in a listen-only mode. Following management’s formal presentation, instructions will be given for the question-and-answer session. [Operator Instructions] I would […]